Clinical trial NCT02527369: Effect of the XP1100RF Therapy on Thighs Circumference Reduction
Official title: Effect of the XP1100RF Therapy on Thighs Circumference Reduction
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Thighs Circumferential Reduction
Subcutaneous Fat Cell Disruption
Keywords: Fat Reduction
Lipolysis
Lead sponsor: BTL Industries Ltd.
Sponsor class: INDUSTRY
First posted: 2015-08-19
Enrollment: 38
Sex: ALL
Minimum age (years): 22
Maximum age (years): 70
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: NA
Intervention model: SINGLE_GROUP
Primary purpose: TREATMENT

Brief summary: This study was designed to demonstrate safety and efficacy of the XP1100RF for non-invasive temporary reduction of thighs circumference by disruption of adipocyte cells.

Detailed description: This study is a prospective, single-arm, open label study of thighs circumference reduction following 4 treatment sessions delivered once a week over a 4-week period. The objective of the study is to demonstrate the effectiveness of the treatment after 30-day in achieving thighs circumference reduction of ≥1 cm relative to the base line assessment.

Eligibility criteria: Inclusion Criteria:

* Body Mass Index (BMI) of 20 to 35 kg/m2.
* Subjects willing and able to abstain from partaking in any treatments other than the study procedure to promote body contouring and/or weight loss during study participation.
* Subjects willing and able to maintain his/her regular (pre-procedure) diet and exercise regimen without effecting significant change in either direction during study participation.

Exclusion Criteria:

* Implanted electronic device such as a cardiac pacemaker, bladder stimulator, spinal cord stimulator or electrodes for a myoelectric prosthesis, etc.
* Diabetics dependent on insulin or oral hypoglycemic medications
* Known cardiovascular disease such as arrhythmias, congestive heart failure
* Cardiac surgeries such as cardiac bypass, heart transplant surgery, pacemakers.
* Prior surgical interventions for body sculpting of thighs such as liposuction
* Medical, physical or other contraindications for body sculpting/ weight loss
* Current use of medication known to affect weight levels and/or cause bloating or swelling and for which abstinence during the course of study participation is not safe or medically prudent
* Any medical condition known to affect weight levels and/or to cause bloating or swelling
* Active infection, wound or other external trauma to the area to be treated
* Pregnant, breast feeding, or planning pregnant before the end of the study
* Serious mental health illness
* Active or recurrent cancer or current chemotherapy and/or radiation treatment
* Negative affection to heat

Primary outcomes:
measure: Thighs Circumference Reduction from Baseline at 30 days Follow Up
timeFrame: 30 days Follow Up
Secondary outcomes:
measure: Adverse Events
timeFrame: 30 days Follow Up
measure: Adverse Events
timeFrame: 3 months Follow Up
measure: Subject satisfaction assessed by questionnaires
timeFrame: 30 days Follow Up
Other outcomes:
Locations:
Study officials:
affiliation: Aesthe Beauty Clinic
name: Radina Denkova, MD
role: PRINCIPAL_INVESTIGATOR
References: